NOV 21, 2018 09:00 AM PST

Current Controversies in the Epidemiology, Diagnosis, and Management of Vaginal Infections

SPONSORED BY: Roche Molecular Diagnostics
C.E. CREDITS: P.A.C.E. CE | RACE
Speakers
  • Associate Professor, Medicine/Infectious Diseases - University of Alabama at Birmingham School of Medicine
    Biography
      Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Her clinical and research interests focus on HIV and sexually transmitted diseases (specifically vaginal infections) among sexual minority women of color and women with increased numbers of recent sexual partners. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.

    Abstract:
    DATE: November 21,2018
    TIME:  09:00am PST, 12:00pm EST
     
    Vaginal infections are a source of considerable morbidity among women. It is estimated that there are more than 10 million office visits per year due to vaginal infections. The three main causes of infectious vaginitis are vulvovaginal candidiasis (VVC), trichomoniasis, and bacterial vaginosis (BV). Each one may cause distressing vaginal symptomatology and the latter two may cause upper genital tract complications. These infections may also contribute to the transmission and acquisition of HIV. This webinar reviews current controversies in the epidemiology, diagnosis, and management of vaginal infections, particularly BV and trichomoniasis. It will include a discussion as to whether or not BV is a sexually transmitted infection, the pathogenesis of incident BV and the role of the BV biofilm, and updated BV treatment recommendations. With regards to trichomonas, the webinar will discuss whether or not it should be a reportable disease, new diagnostic methods, and updated treatment recommendations.
     
    At the end of the webinar, learners should be able to:
    • Describe the epidemiology of BV, particularly as it relates to sexual transmission
    • Be knowledgeable on updated treatment options for BV and trichomonas
    • Be knowledgeable on currently available trichomonas nucleic acid amplification tests

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    Loading Comments...